Carl Zeiss Meditec AG Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Carl Zeiss Meditec AG stock has a consensus rating of "Hold" and an average price target of €28.34. The average 1-year stock price forecast is 9.40% lower than the current stock price, while the lowest is €21.70 (-30.63%) and the highest is €35.00 (+11.89%).

Price Target: €28.34 (-9.40%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	€21.70	€28.34	€28.00	€35.00
Change	-30.63%	-9.40%	-10.49%	+11.89%

Analyst Ratings

The average analyst rating for Carl Zeiss Meditec AG stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	0	0	0
Hold	13	13	13	14	14	13
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	16	16	16	16	16	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Adlington J.P. Morgan	J.P. Morgan	Sell Maintains €21.70	Sell	Maintains	€21.70	-30.63%	Jul 17, 2026
Falko Friedrichs Deutsche Bank	Deutsche Bank	Hold Maintains €30.00 → €28.00	Hold	Maintains	€30.00 → €28.00	-10.49%	Jul 14, 2026
Jonathon Unwin Barclays	Barclays	Hold Maintains €28.00	Hold	Maintains	€28.00	-10.49%	Jul 8, 2026
Susannah Ludwig Bernstein	Bernstein	Hold Maintains €26.10	Hold	Maintains	€26.10	-16.56%	Jul 7, 2026
Richard Felton Goldman Sachs	Goldman Sachs	Hold Maintains €31.00 → €28.00	Hold	Maintains	€31.00 → €28.00	-10.49%	May 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

2.18B

from 2.23B

-2.27%

from 2.23B

Revenue Next Year

2.29B

from 2.18B

5.16%

from 2.18B

EPS This Year

1.33

from -

EPS Next Year

1.74

from 1.33

30.87%

from 1.33

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026
Revenue	1.65B	1.90B	2.09B	2.07B	2.23B	2.18B
Revenue Growth	23.31%	15.55%	9.80%	-1.11%	7.82%	-2.27%
Gross Profit	967.21M	1.13B	1.21B	1.09B	1.18B	1.11B
Gross Margin	58.73%	59.26%	57.71%	52.69%	52.76%	50.83%
Operating Income	370.38M	397.68M	349.06M	177.21M	223.30M	149.38M
Net Income	236.28M	293.91M	290.40M	178.73M	141.21M	89.09M
EPS	-	-	-	-	-	1.33
Forward PE	57.14	34.30	25.66	27.99	20.77	23.55
Dividend / Share	0.90	1.10	1.10	0.60	0.55	0.45
Dividend Growth	-	22.22%	-	-45.45%	-8.33%	-18.82%
Free Cash Flow	59.29M	132.07M	73.93M	783.80M	87.32M	87.62M
No. Analysts	-	-	-	-	-	12

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	2.2B
Avg	2.2B
Low	2.1B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	0.2%
Avg	-2.3%
Low	-4.1%

EPS Forecast

Chart

EPS	2026	2027	2028
High	1.56
Avg	1.33
Low	1.14

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-32.7%
Avg	-42.7%
Low	-50.9%